$3.22▴ 21.93%
End-of-day close · 2026-08-06
What most investors miss
Trends, drivers and alerts — the full picture.
Profit → Cash
Not enough data yet
Valuation
Not enough data yet
Not enough valuation history to place this in context.
Revenue growth
Not enough data yet
Not enough revenue history to measure growth.
Leverage
Not enough data yet
More coming: dilution / share-count creep.
✦ The read
Park Ha Biological Technology Co., Ltd. - Class A Ordinary Shares's earnings-quality signal is not available yet.
Key numbers
Recent news
Sentiment · last 30 days4 articles
0 bullish0 neutral4 bearish
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Park Ha Biological Technology Co., Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - PHH, BYAH
BYAH Class Action Reminder - Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Park Ha Biological Technology Co., Ltd. Class Action
Bronstein, Gewirtz & Grossman LLC Urges Park Ha Biological Technology Co., Ltd. Investors to Act: Class Action Filed Alleging Investor Harm
Park Ha Biological Technology (BYAH) Stock Surges Over 41% After Hours: Why Is It Moving?